Aurobindo receives NAM Finland Approval for its facility at UNIT-VI

Aurobindo Pharma Ltd has announced that NAM (National Agency for Medicines), Finland has approved its facility at Unit-VI to manufacture Cefuroxime injectable 750mg and 1500mg. The Finnish authorities were satisfied regarding the manufacturing practices at the site and stated that it fulfills the prescribed EU-GMP standards.

This facility is situated on a 15-acre land in Chitkul village, Patancheru mandal of Medak district.

In BSE, the stock was down Rs.16.15 (-2.42%) at Rs.650.

Source : Equity Bulls

Keywords